c-Fms-IN-7

c-Fms-IN-7

• CAS Number: 1313408-89-7
• UNSPSC Description: c-Fms-IN-7 is a cFMS inhibitor extracted from patent WO2011079076A1, example159, has an IC50 of 18.5 nM[1].
• Target Antigen: c-Fms
• Type: Reference compound
• Related Pathways: Protein Tyrosine Kinase/RTK
• Applications: COVID-19-immunoregulation
• Field of Research: Cancer; Inflammation/Immunology
• Assay Protocol: https://www.medchemexpress.com/c-fms-in-7.html
• Solubility: 10 mM in DMSO
• Smiles: O=C(C1=CN=C2C=C(SC)C=CN21)NC3=CC=CC4=C3C(C5CC5)=NN4CC6=NC(C)=CC=C6
• Molecular Weight: 468.57
• References & Citations: [1]Mark Laurence Boys，et al. Substituted n-(1h-indazol-4-yl)imidazo[1, 2-a]pyridine-3- carboxamide compounds as cfms inhibitors. WO2011079076A1
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported